Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation
- PMID: 9550370
Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation
Abstract
CTL recognize peptides derived from protein Ags bound to MHC-class I molecules. Proteasomes probably participate in the generation of these peptide epitopes. We investigated the role of proteasomes in the presentation of endogenously synthesized short viral proteins. To this end, we employed proteasome and cysteine protease inhibitors and two closely related recombinant vaccinia viruses that code for 17- and 19-amino acid-long products encompassing murine CMV 9pp89 epitope. Presentation of both minigene products required processing to shorter peptides and was independent of ubiquitination. Proteasomes were necessary for processing the 17-mer product, and cysteine proteases were not required. In contrast, the 19-mer product could be processed in parallel either by proteasomes or by cysteine proteases independently. These results highlight the diversity of alternative processing pathways even for short peptidic Ags, provide evidence for the involvement of cysteine proteases in MHC class I presentation, and show that cleavage by cysteine proteases is governed by sequences flanking the epitope.
Similar articles
-
Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.J Immunol. 1997 Apr 1;158(7):3227-34. J Immunol. 1997. PMID: 9120278
-
The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?J Immunol. 1997 Jul 15;159(2):554-64. J Immunol. 1997. PMID: 9218569
-
Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.J Immunol. 2000 May 15;164(10):5070-7. doi: 10.4049/jimmunol.164.10.5070. J Immunol. 2000. PMID: 10799863
-
The proteasome activator 11 S REG (PA28) and class I antigen presentation.Biochem J. 2000 Jan 1;345 Pt 1(Pt 1):1-15. Biochem J. 2000. PMID: 10600633 Free PMC article. Review.
-
Post-proteasomal antigen processing for major histocompatibility complex class I presentation.Nat Immunol. 2004 Jul;5(7):670-7. doi: 10.1038/ni1089. Nat Immunol. 2004. PMID: 15224092 Review.
Cited by
-
Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.PLoS Pathog. 2015 Mar 17;11(3):e1004725. doi: 10.1371/journal.ppat.1004725. eCollection 2015 Mar. PLoS Pathog. 2015. PMID: 25781895 Free PMC article.
-
Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity.Mol Cell Biochem. 2001 Jan;217(1-2):21-33. doi: 10.1023/a:1007267814251. Mol Cell Biochem. 2001. PMID: 11269662
-
Feline degenerative joint disease: a genomic and proteomic approach.J Feline Med Surg. 2013 Jun;15(6):466-77. doi: 10.1177/1098612X12470652. Epub 2013 Jan 7. J Feline Med Surg. 2013. PMID: 23295270 Free PMC article.
-
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.J Exp Med. 2004 May 17;199(10):1421-31. doi: 10.1084/jem.20040191. J Exp Med. 2004. PMID: 15148340 Free PMC article.
-
Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.J Immunol. 2010 May 1;184(9):5193-9. doi: 10.4049/jimmunol.1000050. Epub 2010 Mar 26. J Immunol. 2010. PMID: 20348426 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous